ArticleACR open rheumatology2023

Journal Club: Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus.

Afroditi Boulougoura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.